Baudax Bio "announced the pricing of its public offering of an aggregate of 3,478,262 shares of its common stock, together with accompanying common stock purchase warrants, at a public offering price of $1.15 per share and accompanying warrants."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BXRX:
- Baudax Bio Announces Pricing of $4 Million Public Offering
- Baudax Bio Soars after Positive Topline Data
- Baudax Bio says BX1000 met primary endpoint in Phase 2 trial
- Baudax Bio to Host Key Opinion Leader Webinar to Discuss Results of Phase 2 BX1000 Trial
- Three new option listings and option delistings on April 17th
